108例颌骨成釉细胞瘤临床分析

上海口腔医学 ›› 2014, Vol. 23 ›› Issue (4): 494-497.

108例颌骨成釉细胞瘤临床分析

丁存善¹, 王荃¹, 高振然², 张竹涟³

1.泰州职业技术学院医学技术学院,江苏泰州 225300;
2.泰州市人民医院口腔科,江苏泰州 225300;
3.靖江市人民医院口腔科,江苏泰州 225300

收稿日期:2014-01-22 出版日期:2014-08-20 发布日期:2014-10-20
通讯作者: 丁存善,Fax:0523-86664720,E-mail:502082760@qq.com
作者简介:丁存善(1963-), 男, 学士, 副主任医师, 副教授

Clinical analysis of 108 cases of jaw ameloblastoma

DING Cun-shan¹, WANG Quan¹, GAO Zhen-ran², ZHANG Zhu-lian³

1.Medical Technical College, Taizhou Polytechnic College. Taizhou 225300;
2. Department of　Stomatology, Taizhou People’s Hospital. Taizhou 225300;
3. Department of Stomatology, Jingjiang People’s Hospital. Taizhou 225300, Jiangsu Province, China

Received:2014-01-22 Online:2014-08-20 Published:2014-10-20

摘要/Abstract

摘要： 目的:回顾108例成釉细胞瘤的发病年龄、性别、部位、病理类型、手术方式及预后,探讨其内在联系。方法:108例患者按年龄分为7组,分析各年龄段成釉细胞瘤的发生比例、发病部位、病理类型以及复发率;探讨成釉细胞瘤各病理类型与发病部位及复发率的关系;分析手术方式和复发率的关系。结果:108例患者中,20～39岁占56.48%;男性略多于女性;下颌骨发生比例为81.48%;滤泡型占45.37%、丛状型占62.96%。108例患者平均复发率为32.41%,50岁以上者更高;65例患者刮治术后复发率为43.08%,而43例患者根治术后复发率为16.28%;各病理类型复发率分析,滤泡型为34.69%,丛状型为26.47%,棘皮瘤型和颗粒细胞型各为28.57%。结论:成釉细胞瘤以男性青壮年好发,多见于下颌骨磨牙区、下颌支及下颌角部;滤泡型和丛状型为最常见的病理类型,滤泡型较易复发;与刮治术相比,根治性手术可降低复发率。

关键词: 成釉细胞瘤, 刮治术, 根治性手术

Abstract: PURPOSE: To review the age of onset, gender, sites, pathologic types, operation methods and prognosis, and explore the internal relations in 108 cases of ameloblastoma. METHODS: The patients were divided into 7 groups according to the age, and then the proportion, primary site, pathologic type, and recurrence rate of ameloblastoma in all groups were analyzed. The relationship among pathologic type, recurrence rate and primary site, as well as the relationship between operation methods and recurrence rate were evaluated. RESULTS: In 108 patients, 61 patients were 20-39 years old (56.48%) with more men than women. 88 patients occurred in the mandible(81.48%). Follicular type accounted for 45.37%, and plexiform type accounted for 62.96%. The average recurrence rate of 108 patients was 32.41%, and recurrence was more often in patients over 50 years old. The postoperative recurrence rate of 65 patients treated by curettage was 43.08%, while it was 16.28% in 43 patients treated by radical correction. The recurrent rate was 34.69% in follicular type, 26.47% in plexiform type, and 28.57% in acanthoma type and granular cell type respectively. CONCLUSIONS: Ameloblastoma usually occurs in young men, more frequently in mandibular molar region, ramus and mandibular angle. Follicular type and plexiform type are the most common pathological types. Follicular type relapses more easily. Compared with curettage, radical surgery can reduce the recurrent rate.

Key words: Ameloblastoma, Curettage, Radical surgery

中图分类号:

R739.8

丁存善, 王荃, 高振然, 张竹涟. 108例颌骨成釉细胞瘤临床分析[J]. 上海口腔医学, 2014, 23(4): 494-497.

DING Cun-shan, WANG Quan, GAO Zhen-ran, ZHANG Zhu-lian. Clinical analysis of 108 cases of jaw ameloblastoma[J]. Shanghai Journal of Stomatology, 2014, 23(4): 494-497.

参考文献

[1] 邱蔚六. 口腔颌面外科理论与实践[M]. 北京: 人民卫生出版社, 1998: 625.
[2] Tsai CY, Wei FC, Chang YL, et al. Vastus lateralis muscle flap used for reconstruction of the maxilla after radical resection of recurrent ameloblastoma [J]. Chang Gung Med J, 2006, 29(3): 331-335.
[3] Philipsen HP, Reichart PA, Nikai H, et al. Peripheral ameloblastoma: biological profile based on 160 cases from the literature [J]. Oral Oncol, 2001, 37(1): 17-27.
[4] 于世凤. 口腔组织病理学 [M]. 第5版. 北京: 人民卫生出版社, 2005: 319.
[5] Feinberg SE, Steinberg B. Surgical management of ameloblastoma. Current status of the literature [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1996, 81(4): 383-388.
[6] Reichart PA, Philipsen HP, Sonner S. Ameloblastoma: biological profile of 3677 cases [J]. Eur J Cancer B Oral Oncol, 1995, 31B(2): 86-99.
[7] Siar CH, Lau SH, Ng KH. Ameloblastoma of the jaws: a retrospective analysis of 340 cases in a Malaysian population [J]. J Oral Maxillofac Surg, 2012, 70(3): 608-615.
[8] Siar Ch, Ng KH. Ameloblastoma in Malaysia: 25 years review [J]. Ann Acad Med Singapore, 1993, 22(6): 856-860.
[9] Kameyama Y, Takehana S, Mizohata M, et al. A clinicopathological study of ameloblastomas[J]. Int J Oral Maxillofac Surg, 1987, 16(6): 706-712.
[10] Takahashi K, Miyauchi K, Sato K. Treatment of ameloblastoma in children [J]. Br J Oral Maxillofac Surg, 1998, 36(6): 453-456.
[11] Chidzonga MM, Lopez Perez VM, Portilla Alvarez AL. Ameloblastoma: the Zimbabwean experience over 10 years [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1996, 82(1)1: 38-41.
[12] Butt FM, Guthua SW, Awange DA, et al. The pattern and occurrence of ameloblastoma in adolescents treated at a university teaching hospital, in Kenya: a 13-year study[J]. J Craniomaxillofac Surg, 2012, 40(2): e39-45.
[13] Bedi RS, Chugh A, Pasricha N. Ameloblastic carcinoma of maxilla [J]. Natl J Maxillofac Surg, 2012, 3(1): 70-74.
[14] Herwig MC, Fischer HP, Moore CE, et al. Orbital invasion of a maxillary ameloblastoma [J]. Ophthalmologe, 2013, 110(3): 251-254.
[15] Chala S,Nassih M, Rzin A, et al. Ameloblastoma of the mandible [J]. Rev Stomatol Chir Maxillofac, 2002, 103(4): 247-250.
[16] Sammartino G, Zarrelli C, Urciuolo V, et al. Effectiveness of a new decisional algorithm in managing mandibular ameloblastomas: a 10-years experience[J]. Br J Oral Maxillofac Surg, 2007, 45(4): 306-310.
[17] Zhang J, Gu Z, Jiang L, et al. Ameloblastoma in children and adolescents [J]. Br J Oral Maxillofac Surg, 2010, 48(7): 549-554.
[18] 廖大鹏, 周正炎. 造釉细胞瘤治疗进展 [J].口腔颌面外科杂志, 2000, 10(4): 338-341.